ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 89 filers reported holding ENZO BIOCHEM INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $88,000 | -87.4% | 33,480 | -82.7% | 0.03% | -89.3% |
| Q3 2019 | $697,000 | -16.2% | 193,580 | -21.7% | 0.28% | -17.1% |
| Q2 2019 | $832,000 | -15.7% | 247,130 | -31.7% | 0.34% | -23.1% |
| Q1 2019 | $987,000 | +6.9% | 361,896 | +9.0% | 0.44% | -3.7% |
| Q4 2018 | $923,000 | -44.7% | 332,046 | -18.0% | 0.46% | -29.1% |
| Q3 2018 | $1,668,000 | -9.9% | 405,046 | +13.5% | 0.65% | -7.3% |
| Q2 2018 | $1,851,000 | -1.9% | 356,804 | +3.6% | 0.70% | -5.7% |
| Q1 2018 | $1,887,000 | -10.1% | 344,404 | +33.8% | 0.74% | -9.9% |
| Q4 2017 | $2,098,000 | -20.6% | 257,449 | +2.1% | 0.82% | -26.3% |
| Q3 2017 | $2,641,000 | +108.0% | 252,225 | +119.3% | 1.11% | +85.6% |
| Q2 2017 | $1,270,000 | – | 115,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |